NCT07798999

Brief Summary

Randomized, double-blind, crossover design, interventional study to assess the differences between mixed cathodic/anodic, pure cathodic, and pure anodic stimulation with respect to efficacy, side effect thresholds, symptom control, and quality of life in Parkinson's Disease patients implanted with Boston Scientific Cartesia directional DBS leads in the bilateral STN.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Feb 2026Feb 2027

Study Start

First participant enrolled

February 17, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 20, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 2, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

September 2, 2026

Status Verified

August 1, 2026

Enrollment Period

12 months

First QC Date

June 20, 2026

Last Update Submit

August 31, 2026

Conditions

Keywords

Parkinson DiseaseDBS leadsBoston Scientific Vercise DBS systemCartesia directional leadsAnodicCathodic

Outcome Measures

Primary Outcomes (1)

  • Parkinson's Disease Questionnaire-39 (PDQ-39)

    Patient's preferred stimulation parameter setting (with or without anodic stimulation) determined by their responses to the questionnaire and patient's stated preference. The score ranges from 0-100, with lower scores reflecting better quality of life of patients.

    At the end of patient's participation in the study, 3 months.

Secondary Outcomes (11)

  • Unified Parkinson's Disease Rating Scale (UPDRS) Part III Motor Scores

    Baseline and 4 weeks after each parameter setting.

  • Unified Parkinson's Disease Rating Scale (UPDRS) Part III Motor Sub-scores

    Baseline and 4 weeks after each parameter setting.

  • Clinical Global Impression- Positive Symptoms (CGI-P) Scores Mixed Cathodic/Anodic

    4 weeks following mixed cathodic/anodic stimulation.

  • Clinical Global Impression- Positive Symptoms (CGI-P) Scores Pure Cathodic

    4 weeks following pure cathodic stimulation.

  • Clinical Global Impression- Positive Symptoms (CGI-P) Scores Pure Anodic

    4 weeks following pure anodic stimulation.

  • +6 more secondary outcomes

Study Arms (3)

Mixed Cathodic/Anodic

EXPERIMENTAL
Device: Mixed Cathodic/Anodic

Cathodic

EXPERIMENTAL
Device: Pure Cathodic

Anodic

EXPERIMENTAL
Device: Pure Anodic

Interventions

Mixed cathodic/anodic stimulation setting on the Boston Scientific Vercise DBS system.

Mixed Cathodic/Anodic

Pure cathodic stimulation setting on the Boston Scientific Vercise DBS system.

Cathodic

Pure anodic stimulation setting on the Boston Scientific Vercise DBS system.

Anodic

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients that are between the ages of 40-80 years of age.
  • Patients diagnosed with Idiopathic Parkinson's Disease that are treated with bilateral STN DBS Boston Scientific Vercise Cartesia directional leads for at least 3 months.
  • Patients whose DBS settings can be optimized to include anodic and cathodic stimulation.

You may not qualify if:

  • Parkinson's Disease patients implanted with DBS leads outside of FDA labeling.
  • Patients who are not chronically using anodic stimulation parameters.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USF Health STC Department of Neurosurgery and Tampa General Hospital

Tampa, Florida, 33606, United States

Location

Related Publications (7)

  • Volkmann J, Moro E, Pahwa R. Basic algorithms for the programming of deep brain stimulation in Parkinson's disease. Mov Disord. 2006 Jun;21 Suppl 14:S284-9. doi: 10.1002/mds.20961.

    PMID: 16810675BACKGROUND
  • McIntyre CC, Grill WM. Extracellular stimulation of central neurons: influence of stimulus waveform and frequency on neuronal output. J Neurophysiol. 2002 Oct;88(4):1592-604. doi: 10.1152/jn.2002.88.4.1592.

    PMID: 12364490BACKGROUND
  • McIntyre CC, Grill WM. Selective microstimulation of central nervous system neurons. Ann Biomed Eng. 2000 Mar;28(3):219-33. doi: 10.1114/1.262.

    PMID: 10784087BACKGROUND
  • Kirsch AD, Hassin-Baer S, Matthies C, Volkmann J, Steigerwald F. Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects. Parkinsonism Relat Disord. 2018 Oct;55:61-67. doi: 10.1016/j.parkreldis.2018.05.015. Epub 2018 May 16.

    PMID: 29784559BACKGROUND
  • Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J; German Parkinson Study Group, Neurostimulation Section. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006 Aug 31;355(9):896-908. doi: 10.1056/NEJMoa060281.

    PMID: 16943402BACKGROUND
  • De Jesus S, Almeida L, Shahgholi L, Martinez-Ramirez D, Roper J, Hass CJ, Akbar U, Wagle Shukla A, Raike RS, Okun MS. Square biphasic pulse deep brain stimulation for essential tremor: The BiP tremor study. Parkinsonism Relat Disord. 2018 Jan;46:41-46. doi: 10.1016/j.parkreldis.2017.10.015. Epub 2017 Oct 20.

    PMID: 29102253BACKGROUND
  • Anderson DN, Duffley G, Vorwerk J, Dorval AD, Butson CR. Anodic stimulation misunderstood: preferential activation of fiber orientations with anodic waveforms in deep brain stimulation. J Neural Eng. 2019 Feb;16(1):016026. doi: 10.1088/1741-2552/aae590. Epub 2018 Oct 2.

    PMID: 30275348BACKGROUND

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Yarema Bezchlibnyk

    University of South Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Randomized, double-blind, crossover design, interventional study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Neurosurgery, Department of Neurosurgery, Brain and Spine

Study Record Dates

First Submitted

June 20, 2026

First Posted

September 2, 2026

Study Start

February 17, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2027

Last Updated

September 2, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations